4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-20-000274
EVP Strategy and Corporate Dev sold 2,200 shares at an average $411.20 ($904,637)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pacelli Steven Robert EVP Strategy and Corporate Dev | 2020-09-30 | Sale | −1,900 | $410.28 | $779,527 | 63,318 | D: show line 1 in the form |
| Pacelli Steven Robert EVP Strategy and Corporate Dev | 2020-09-30 | Sale | −100 | $411.10 | $41,110 | 63,218 | D: show line 2 in the form |
| Pacelli Steven Robert EVP Strategy and Corporate Dev | 2020-10-01 | Sale | −200 | $420.00 | $84,000 | 63,018 | D: show line 3 in the form |
| Open-market sales · 2,200 sh · avg $411.20 · $904,637 | |||||||
Loading xslF345X03/edgardoc.xml…